Abbott includes manufacturing in 700 job cuts

Abbott Laboratories ($ABT) said Wednesday that it will eliminate 200 manufacturing jobs in Puerto Rico and at some other sites. As bad as that sounds, it's relatively good news: The company also announced the elimination of about 300 jobs at its stent business in Southern California, and fewer than 200 more from the diagnostics unit at the Lake County, IL, location, reports The Associated Press.

Lake County, near the company's Abbott Park headquarters, has been particularly hard hit recently. One year ago, the drugmaker unveiled plans to cut 1,900 jobs in a restructuring, with about 1,000 of those in the Chicago-area.

In June, by contrast, about 150 Canadian workers benefited from increased demand for nutritional formula Ensure and Similac baby formula. Their terminations were delayed 12 to 18 months beyond what they'd been first told so Abbott could meet demand, as we reported.

Abbott reported a 12% profit increase for the fourth quarter, according to the company announcement.

- see the AP story
- here's more from MarketWatch
- here's the Abbott release

Related Articles:
Abbott delays pink slips due to product demand
Abbott jobs axe hits manufacturing

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.